Jiangxin Liu

518 total citations
22 papers, 429 citations indexed

About

Jiangxin Liu is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Jiangxin Liu has authored 22 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Pharmacology. Recurrent topics in Jiangxin Liu's work include Natural product bioactivities and synthesis (7 papers), Biological Activity of Diterpenoids and Biflavonoids (4 papers) and Alkaloids: synthesis and pharmacology (3 papers). Jiangxin Liu is often cited by papers focused on Natural product bioactivities and synthesis (7 papers), Biological Activity of Diterpenoids and Biflavonoids (4 papers) and Alkaloids: synthesis and pharmacology (3 papers). Jiangxin Liu collaborates with scholars based in China, United States and Germany. Jiangxin Liu's co-authors include Pei Zhou, Qin‐Shi Zhao, Graham C. Walker, Su Wang, Jenny Y. Xue, Sanjay D’Souza, Jessica L. Wojtaszek, Xing‐De Wu, Aijun Ding and Zhigang Li and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Biochemistry.

In The Last Decade

Jiangxin Liu

20 papers receiving 427 citations

Peers

Countries citing papers authored by Jiangxin Liu

Since Specialization

Citations

This map shows the geographic impact of Jiangxin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangxin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangxin Liu more than expected).

Fields of papers citing papers by Jiangxin Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangxin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangxin Liu. The network helps show where Jiangxin Liu may publish in the future.

Co-authorship network of co-authors of Jiangxin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangxin Liu. A scholar is included among the top collaborators of Jiangxin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangxin Liu. Jiangxin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The First Kynurenine 3-Monooxygenase Activator with an Undescribed Skeleton Provides Insight into the Toxicological Mechanism of Gelsemium elegans 2025 ·Organic Letters ·(unknown), (unknown), (unknown), Jiangxin Liu, Xiang‐Hai Cai	0
2	Identification and verification of methylenetetrahydrofolate dehydrogenase 1-like protein as the binding target of natural product pseudolaric acid A 2025 ·Natural Products and Bioprospecting ·(unknown), (unknown), (unknown), Weiya Huang, Liang Zhang, Song Song, Jiangxin Liu	0
3	In vitro and vivo anti-tumor activity and mechanisms of the new cryptotanshinone derivative 11 against hepatocellular carcinoma 2024 ·European Journal of Pharmacology ·(unknown), (unknown), (unknown), Jian Ren, (unknown), (unknown), Qin‐Shi Zhao, Jiangxin Liu	1
4	Discovery and biological evaluation of a new type of dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase from ethnomedicinal plant Dactylicapnos scandens 2023 ·Phytochemistry ·Mei‐Fen Bao, (unknown), (unknown), Jiangxin Liu, Xiang‐Hai Cai	6
5	Hepatic epithelioid angiomyolipoma is scattered and unsuitable for surgery: a case report 2023 ·Journal of International Medical Research ·(unknown), (unknown), (unknown), Jiangxin Liu, (unknown)	5
6	Design, synthesis and biological evaluation of a new class of Hsp90 inhibitors vibsanin C derivatives 2022 ·European Journal of Medicinal Chemistry ·Meng Li, (unknown), (unknown), Jiangxin Liu, (unknown), Qin‐Shi Zhao	7
7	Discovery and biological evaluation of tanshinone derivatives as potent dual inhibitors of indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase 2022 ·European Journal of Medicinal Chemistry ·Jiangxin Liu, Jian Ren, Kun Yang, Shuang Chen, (unknown), Qin‐Shi Zhao	20
8	Eleven undescribed alkaloids from the rhizomes of Sinomenium acutum and their IDO1 and TDO inhibitory activities 2022 ·Phytochemistry ·Ran Bi, (unknown), (unknown), Li‐Yan Peng, Jiangxin Liu, Qin‐Shi Zhao	10
9	Discovery of pseudolaric acid A as a new Hsp90 inhibitor uncovers its potential anticancer mechanism 2021 ·Bioorganic Chemistry ·Jiangxin Liu, Xing‐De Wu, Wenyan Li, (unknown), Kun Yang, Qin‐Shi Zhao	14
10	NCP activates chloroplast transcription by controlling phytochrome-dependent dual nuclear and plastidial switches 2019 ·Nature Communications ·(unknown), Chan Yul Yoo, Jiangxin Liu, He Wang, Jun Cao, Fay‐Wei Li, Kathleen M. Pryer, Tai‐ping Sun, Detlef Weigel, Pei Zhou, Meng Chen	46
11	Isolation, Structural Assignment of Isoselagintamarlin A from Selaginella tamariscina and Its Biomimetic Synthesis 2019 ·Natural Products and Bioprospecting ·Qin‐Feng Zhu, Li‐Dong Shao, Xing‐De Wu, Jiangxin Liu, Qin‐Shi Zhao	9
12	Diterpenoids and sesquiterpenoids from the stem bark of Metasequoia glyptostroboides 2019 ·Phytochemistry ·(unknown), Yanyan Qi, Lin‐Fen Ding, Hui Yang, Jiangxin Liu, Li‐Yan Peng, Liu‐Dong Song, Xun Gong, Xing‐De Wu, Qin‐Shi Zhao	13
13	Identification and Characterization of ShSPI, a Kazal-Type Elastase Inhibitor from the Venom of Scolopendra Hainanum 2019 ·Toxins ·Ning Luan, (unknown), Zilei Duan, Mengyao Ji, (unknown), (unknown), James Mwangi, Mingqiang Rong, Jiangxin Liu, Ren Lai	9
14	Magnograndins J-M, elemane sesquiterpenoids from the leaves of Magnolia grandiflora and their inhibitory effects on nitric oxide production 2019 ·Phytochemistry Letters ·Lin‐Fen Ding, Jiangxin Liu, (unknown), De‐Shen Wang, Wei Nie, Liu‐Dong Song, Xing‐De Wu, Qin‐Shi Zhao	13
15	Metabolomic signature associated with reproduction-regulated aging in Caenorhabditis elegans 2017 ·Aging ·Qin-Li Wan, (unknown), Jiangxin Liu, Aijun Ding, (unknown), Zhigang Li, Gui-Sheng Wu, Huai‐Rong Luo	49
16	Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors 2017 ·Journal of Medicinal Chemistry ·Li‐Dong Shao, Jia Su, Baixin Ye, Jiangxin Liu, Zhili Zuo, Yan Li, Yueying Wang, Chengfeng Xia, Qin‐Shi Zhao	38
17	A sodium channel inhibitor ISTX-I with a novel structure provides a new hint at the evolutionary link between two toxin folds 2016 ·Scientific Reports ·Mingqiang Rong, Jiangxin Liu, Meilin Zhang, Wang Gan, Gang Zhao, Guodong Wang, Ya‐Ping Zhang, Kaifeng Hu, Ren Lai	7
18	Specific Interaction of the Transcription Elongation Regulator TCERG1 with RNA Polymerase II Requires Simultaneous Phosphorylation at Ser2, Ser5, and Ser7 within the Carboxyl-terminal Domain Repeat 2013 ·Journal of Biological Chemistry ·Jiangxin Liu, Shilong Fan, Chul‐Jin Lee, Arno L. Greenleaf, Pei Zhou	22
19	Multifaceted Recognition of Vertebrate Rev1 by Translesion Polymerases ζ and κ 2012 ·Journal of Biological Chemistry ·Jessica L. Wojtaszek, Jiangxin Liu, Sanjay D’Souza, Su Wang, Jenny Y. Xue, Graham C. Walker, Pei Zhou	72
20	Solution structure of BRD7 bromodomain and its interaction with acetylated peptides from histone H3 and H4 2007 ·Biochemical and Biophysical Research Communications ·Hongbin Sun, Jiangxin Liu, Jiahai Zhang, (unknown), Hongda Huang, Chao Xu, Haiming Dai, Jihui Wu, Yunyu Shi	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact